Stroke trials in Australia

In Australia 26 Also abroad 2130

20 of 26 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Adelaide, Blacktown, Box Hill, Brisbane, Camberwell, Deakin, Frankston, Garran, Geelong, Ipswich, Norwood, Sippy Downs, South Brisbane, Sydney, Waitara
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
Phase 3Taking people
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Where
Adelaide, Box Hill, Campbelltown, Clayton, Liverpool, New Lambton Heights, Parkville
Age
18 years and over
People
1,325 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07361302 · EU 2025-522542-40-00
Phase 3Taking people
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Where
Melbourne, Sydney
Age
18 years and over
People
4,000 worldwide
Run by
University of Calgary
See details and how to joinNCT06320431
Phase 3Taking people
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Where
Sydney
Age
18 years and over
People
1,500 worldwide
Run by
University of Calgary
See details and how to joinNCT07687056
Phase 2Taking people
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Where
Adelaide, Clayton, Murdoch, New Lambton Heights, Parkville, Woolloongabba
Age
18 years and over
People
228 worldwide
Run by
Basking Biosciences, Inc.
See details and how to joinNCT06226805
Phase 3Taking people
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Where
Box Hill, Perth
Age
18 years and over
People
6,150 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT04774159
No phaseTaking people
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
Where
Sydney
Age
18 years and over
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06352619
Phase 3Taking people
ACT-GLOBAL Adaptive Platform Trial for Stroke
Where
Sydney
Age
18 years and over
People
20,000 worldwide
Run by
The George Institute
See details and how to joinNCT06352632
Phase 3Taking people
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
Where
Sydney
Age
18 years to 80 years
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06763055
Phase 4Taking people
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Where
Adelaide, Clayton, Sydney
Age
18 years and over
People
3,500 worldwide
Run by
Region Skane
See details and how to joinNCT06429332
Phase 2/3Taking people
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Where
Adelaide, Gold Coast, Melbourne, Perth, Sydney, Townsville
Age
18 years and over
People
462 worldwide
Run by
University of Melbourne
See details and how to joinNCT05892510
Phase 2/3Taking people
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Where
Adelaide, Ballarat, Bankstown, Gold Coast, Melbourne, Murdoch, Newcastle, Sydney, Woolloongabba
Age
18 years and over
People
688 worldwide
Run by
University of Melbourne
See details and how to joinNCT05105633 · EU 2024-513444-28-00
Phase 4Taking people
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Where
Adelaide, Bankstown, Birtinya, Box Hill, Camperdown, Concord, Garran, Herston, Liverpool, Newcastle, Perth, Redcliffe, Wangaratta, Westmead
Age
55 years and over
People
2,270 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT03968393 · EU 2023-509142-35-00
No phaseTaking people
Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)
Where
Multiple Locations
Age
18 years and over
People
2,312 worldwide
Run by
Atrial Fibrillation Network
See details and how to joinNCT06324188
Phase 2Taking people
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Where
Adelaide, Box Hill, Camperdown, Liverpool, New Lambton Heights, Parkville, Randwick
Age
18 years and over
People
80
Run by
The Florey Institute of Neuroscience and Mental Health
See details and how to joinNCT05363397
Phase 2Taking people
Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion
Where
Newcastle, St Leonards
Age
18 years and over
People
78
Run by
ThromBio Pty. Ltd.
See details and how to joinNCT06813651
Phase 3Taking people
High Dose Steroids in Children With Stroke
Where
Melbourne, Randwick, Westmead
Age
6 months to 17 years
People
70 worldwide
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT04873583 · EU 2022-500631-36-00
No phaseTaking people
Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
Where
Adelaide, Brisbane, Melbourne, Newcastle, Parkville, Southport, Sydney
Age
18 years and over
People
240
Run by
University of Melbourne
See details and how to joinNCT04434807
No phaseTaking people
Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
Where
Clayton
Age
18 years and over
People
30
Run by
Transverse Medical, Inc.
See details and how to joinNCT06962371
No phaseNot yet taking people in Australia
Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke
Where
Adelaide, Melbourne, Newcastle, Parkville, St Leonards
Age
18 years and over
People
30
Run by
University of Melbourne
See details and how to joinNCT06495671